Astellas Pharma Inc. (FRA:YPH)

Astellas Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	20,945	15,998	18,058	23,412	26,092	24,354
Market Cap Growth	25.31%	-11.41%	-22.87%	-10.27%	7.14%	-7.27%
Enterprise Value	23,418	20,542	21,852	20,799	23,501	22,002
Last Close Price	11.63	8.55	9.10	11.49	12.08	10.99
PE Ratio	29.12	51.03	172.88	34.26	28.37	26.22
PS Ratio	1.81	1.35	1.84	2.23	2.72	2.53
PB Ratio	2.26	1.71	1.85	2.24	2.41	2.28
P/TBV Ratio	22.97	-	-	5.48	6.59	7.02
P/FCF Ratio	9.94	16.44	21.92	11.61	15.53	11.48
P/OCF Ratio	9.10	13.31	17.09	10.32	13.67	10.30
EV/Sales Ratio	2.14	1.74	2.22	1.98	2.45	2.29
EV/EBITDA Ratio	7.67	7.19	12.63	8.90	10.64	8.83
EV/EBIT Ratio	11.74	12.62	28.62	12.97	14.53	11.38
EV/FCF Ratio	11.11	21.11	26.53	10.31	13.98	10.37
Debt / Equity Ratio	0.46	0.62	0.63	0.14	0.15	0.20
Debt / EBITDA Ratio	1.32	2.03	3.57	0.61	0.72	0.86
Debt / FCF Ratio	2.02	5.95	7.50	0.70	0.94	1.01
Asset Turnover	0.58	0.55	0.53	0.63	0.56	0.54
Inventory Turnover	1.32	1.28	1.38	1.76	1.60	1.56
Quick Ratio	0.76	0.79	0.69	1.13	1.05	1.15
Current Ratio	1.03	1.13	0.93	1.45	1.34	1.47
Return on Equity (ROE)	7.95%	3.26%	1.10%	6.65%	8.72%	9.01%
Return on Assets (ROA)	6.68%	4.77%	2.58%	6.05%	5.92%	6.83%
Return on Invested Capital (ROIC)	15.96%	11.63%	4.72%	12.83%	12.80%	15.28%
Return on Capital Employed (ROCE)	17.40%	11.60%	5.50%	13.40%	13.30%	14.90%
Earnings Yield	3.43%	1.96%	0.58%	2.92%	3.52%	3.81%
FCF Yield	10.07%	6.08%	4.56%	8.62%	6.44%	8.71%
Dividend Yield	3.96%	5.35%	4.71%	3.62%	3.07%	2.94%
Payout Ratio	106.09%	254.19%	684.38%	101.66%	68.69%	63.15%
Buyback Yield / Dilution	0.07%	0.14%	1.39%	1.38%	0.41%	1.03%
Total Shareholder Return	4.03%	5.49%	6.11%	5.00%	3.48%	3.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.